Table 1.
Treatment | Title of Trial | Primary outcome (study type) | Clinical phase status |
---|---|---|---|
Baclofen (Programmable implantable pump) | Continuous intrathecal baclofen infusion for the management of chronic spasticity | Muscle spasticity (interventional) | Phase III not yet recruiting |
https://www.clinicaltrials.gov/ct2/show/NCT01051128?term=spinal+cord+injury+AND+spasticity&recr=Open&rank=10 | |||
Cannabinoids (nabilone) | Effect of cannabinoids on spasticity in spinal cord injured persons | Muscle spasticity (interventional) | Phase II not yet recruiting |
https://www.clinicaltrials.gov/ct2/show/NCT01222468?term=spinal+cord+injury+AND+spasticity&recr=Open&rank=2 | |||
Pregabalin (Lyrica) - Pfizer, New York City, NY | Study of pregabalin in the prevention of central neuropathic pain in acute spinal cord injury | Neuropathic pain and muscle spasticity (interventional) | Phase III not yet recruiting |
https://www.clinicaltrials.gov/ct2/show/NCT00879021?term=spinal+cord+injury+AND+spasticity&recr=Open&rank=7 |
SCI = spinal cord injury.